» Articles » PMID: 25954907

Effects of Ganoderma Lucidum (Higher Basidiomycetes) Extracts on the MiRNA Profile and Telomerase Activity of the MCF-7 Breast Cancer Cell Line

Overview
Date 2015 May 9
PMID 25954907
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Ganoderma lucidum is a medicinal higher Basidiomycetes mushroom that exerts anticancer effects through several different mechanisms. This study investigated the effects of G. lucidum on the telomerase activity and microRNA (miRNA) profiles of MCF-7 cells. According to the cytotoxicity results, the G. lucidum ether extract exhibits the highest cytotoxic potency; therefore it was chosen for the subsequent telomerase activity assay and miRNA profiling. The telomerase activity observed in the cells treated with a half-maximal inhibitory concentration of G. lucidum ether extract (100 µg/mL in dimethyl sulfoxide) was 32.2% lower than that of the control cells treated with 1% dimethyl sulfoxide. Among 1066 miRNAs, the most downregulated miRNA was hsa-miR-27a* (4.469-fold), and the most upregulated miRNA was hsa-miR-1285 (10.462-fold). A database search revealed the predicted miRNAs that target the catalytic subunit of the telomerase enzyme telomerase reverse transcriptase, and only miR-3687 (upregulated 2.153-fold) and miR-1207-5p (upregulated 2.895-fold) were changed by at least 2-fold. The miRNA profile changes demonstrated in this study provide a data set regarding their effects on the pathways that regulate telomerase activity in MCF-7 breast cancer cells treated with G. lucidum. These data should aid the development of novel cancer treatment strategies.

Citing Articles

Identification of key differentially expressed MicroRNAs in cancer patients through pan-cancer analysis.

Hu Y, Dingerdissen H, Gupta S, Kahsay R, Shanker V, Wan Q Comput Biol Med. 2018; 103:183-197.

PMID: 30384176 PMC: 6279243. DOI: 10.1016/j.compbiomed.2018.10.021.


MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).

Graham E, Mallet J, Jambi M, Nishioka H, Homma K, Matar C Cancer Biol Ther. 2017; 18(10):765-774.

PMID: 28886271 PMC: 5678688. DOI: 10.1080/15384047.2017.1373211.


spp.: A Promising Adjuvant Treatment for Breast Cancer.

Suarez-Arroyo I, Loperena-Alvarez Y, Rosario-Acevedo R, Martinez-Montemayor M Medicines (Basel). 2017; 4(1).

PMID: 28758107 PMC: 5533290. DOI: 10.3390/medicines4010015.


Metabolism-related microRNAs in maternal breast milk are influenced by premature delivery.

Carney M, Tarasiuk A, DiAngelo S, Silveyra P, Podany A, Birch L Pediatr Res. 2017; 82(2):226-236.

PMID: 28422941 PMC: 5552431. DOI: 10.1038/pr.2017.54.


The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.

Starska K, Forma E, Nowacka-Zawisza M, Lewy-Trenda I, Ciesielski P, Pietruszewska W Tumour Biol. 2015; 37(4):4541-57.

PMID: 26503213 DOI: 10.1007/s13277-015-4276-3.